Randomized, double blind placebo-controlled studies to evaluate the safety and tolerability of a novel Llama-derived anti-rotavirus VHH fragment in human volunteers (Part-I), and its therapeutic efficacy in children with rotavirus diarrhoea (Part-II)
Download
Microsoft Word
(736 kB)